Literature DB >> 16227230

Development and characterization of a transient-replication assay for the genotype 2a hepatitis C virus subgenomic replicon.

Paul Targett-Adams1, John McLauchlan1.   

Abstract

Dicistronic, subgenomic hepatitis C virus (HCV) replicons were constructed containing sequences from JFH1, a genotype 2a strain, that also incorporated the firefly luciferase gene under the control of the HCV internal ribosome entry site element. Luciferase activity in Huh-7 cell extracts containing in vitro-transcribed subgenomic JFH1 RNA was monitored over a 72 h period to examine early stages of HCV replication in the absence of any selective pressure. Enzyme activities produced by the replicon were almost 200-fold greater than those generated from corresponding genotype 1b replicons and correlated with an accumulation of NS5A protein and replicon RNA. Transient replication was sensitive to IFN treatment in a dose-dependent manner and, in addition to Huh-7 cells, the U2OS human osteosarcoma cell line supported efficient replication of the JFH1 replicon. Thus, this system based on JFH1 sequences offers improvements over prior genotype 1b replicons for quantitative measurement of viral RNA replication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227230     DOI: 10.1099/vir.0.81334-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  38 in total

1.  Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase.

Authors:  Jamel Mankouri; Philip R Tedbury; Sarah Gretton; Mair E Hughes; Stephen D C Griffin; Mark L Dallas; Kevin A Green; D Grahame Hardie; Chris Peers; Mark Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  In-cell click labelling of small molecules to determine subcellular localisation.

Authors:  Lyn H Jones; David Beal; Matthew D Selby; Owen Everson; George M Burslem; Peter Dodd; Jared Millbank; Thien-Duc Tran; Florian Wakenhut; Emily J S Graham; Paul Targett-Adams
Journal:  J Chem Biol       Date:  2010-11-18

3.  A Massively Parallel Selection of Small Molecule-RNA Motif Binding Partners Informs Design of an Antiviral from Sequence.

Authors:  Jessica L Childs-Disney; Tuan Tran; Balayeshwanth R Vummidi; Sai Pradeep Velagapudi; Hafeez S Haniff; Yasumasa Matsumoto; Gogce Crynen; Mark R Southern; Avik Biswas; Zi-Fu Wang; Timothy L Tellinghuisen; Matthew D Disney
Journal:  Chem       Date:  2018-09-13       Impact factor: 22.804

4.  A human proteome microarray identifies that the heterogeneous nuclear ribonucleoprotein K (hnRNP K) recognizes the 5' terminal sequence of the hepatitis C virus RNA.

Authors:  Baochang Fan; Kuan-Yi Lu; F X Reymond Sutandy; Yi-Wen Chen; Kouacou Konan; Heng Zhu; C Cheng Kao; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2013-10-10       Impact factor: 5.911

5.  Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122.

Authors:  Liang-Tzung Lin; Ryan S Noyce; Tram N Q Pham; Joyce A Wilson; Gary R Sisson; Thomas I Michalak; Karen L Mossman; Christopher D Richardson
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

6.  Comparative study of the genetic barriers and pathways towards resistance of selective inhibitors of hepatitis C virus replication.

Authors:  Leen Delang; Inge Vliegen; Mathy Froeyen; Johan Neyts
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

7.  The hepatitis C virus NS4B protein can trans-complement viral RNA replication and modulates production of infectious virus.

Authors:  Daniel M Jones; Arvind H Patel; Paul Targett-Adams; John McLauchlan
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

8.  Modulation of hepatitis C virus genome encapsidation by nonstructural protein 4B.

Authors:  Qingxia Han; David Manna; Kerry Belton; Richard Cole; Kouacou V Konan
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

9.  DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A.

Authors:  Lotte Coelmont; Xavier Hanoulle; Udayan Chatterji; Carola Berger; Joke Snoeck; Michael Bobardt; Precious Lim; Inge Vliegen; Jan Paeshuyse; Grégoire Vuagniaux; Anne-Mieke Vandamme; Ralf Bartenschlager; Philippe Gallay; Guy Lippens; Johan Neyts
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

10.  Visualization of double-stranded RNA in cells supporting hepatitis C virus RNA replication.

Authors:  Paul Targett-Adams; Steeve Boulant; John McLauchlan
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.